A organização Scientists Without Borders, juntamente com a New York Academy of Science, promoverá um webminar sobre tuberculose na 3a-f próxima, 06 de abril.
Tuberculosis: Novel Therapies through Knowledge of the Genetics of the Causative Agent
Tuberculosis kills close to two million people each year and infecting strains of Mycobacterium tuberculosis resistant to standard regimens are increasingly more prevalent. There is a clear need for new TB drugs and for new drug discovery paradigms. It has been more than 10 years since the sequence of M. tuberculosis genome was published. The accumulated knowledge from the intervening years, together with recent use of innovative genetic techniques, has shifted the emphasis in TB drug discovery from empirical approaches to hypothesis-driven processes. These new processes can accelerate identification and validation of pharmaceutical targets, unveil resistance mechanisms, and present new compound screening strategies and drug development pathways. This symposium will highlight recent advances in these areas as well as deeper insights into the pathophysiology of the disease that has been enabled by genetic tools.
This symposium will also be broadcast as a live webinar, providing an opportunity for our world-wide audiences to participate in this exciting and timely discussion.
To Register For This Webinar & For More Information www.nyas.org/TB
Nenhum comentário:
Postar um comentário